All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

FDA recall notice · announced August 30, 2023 · Inmar Supply Chain Solutions

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

Reason for recall

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

Notes

Distribution: Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.
Lot/code information: Miscellaneous
Quantity: Unknown
Status: Ongoing
Products in this recall event:
- All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar. (D-1104-2023)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.